Agriculture and pharmaceutical giant Bayer [August 20] agreed [to] a $7.6 billion deal to sell its animal health business to U.S.-based animal health company Elanco …. The deal with Elanco means Bayer will now no longer make products that prevent and treat diseases in farm animals and pets.
…
Bayer finds itself in a tough political situation after its $63 billion acquisition of glyphosate-maker Monsanto last year. Having taken on the liability for the controversial weedkiller, Bayer has been facing a wave of claims from plaintiffs saying glyphosate caused their cancer …. Bayer …. denied any link between the glyphosate lawsuits and the animal health sell-off.
Read full, original article: Bayer sells animal health business (Behind paywall)
